Skip to Content
US Videos

How Will M&A Affect Pharma Balance Sheets?

Even if a potential Sanofi/Genzyme deal foretells a wave of consolidation, investors shouldn't worry about big pharma credit quality, says Morningstar's Julie Stralow.

Mentioned: ,

Jeremy Glaser: How will pharma M&A impact health-care balance sheets? I'm Jeremy Glaser with I'm here today with Julie Stralow, senior analyst. Take a look at the Genzyme deal or the potential Genzyme deal and see how M&A wave across the industry could impact our credit ratings.

Julie, thanks for joining me.

Jeremy Glaser does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.